Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ CardiffĀ 
WelshClear Cookie - decide language by browser settings

Prostate transglutaminase: a unique transglutaminase and its role in prostate cancer

Jiang, Wen Guo and Ablin, Richard J. 2011. Prostate transglutaminase: a unique transglutaminase and its role in prostate cancer. Biomarkers in Medicine 5 (3) , pp. 285-291. 10.2217/bmm.11.36

Full text not available from this repository.


Prostate transglutaminase-4, also known as TGM4 or transglutaminase P, belongs to the prostate transglutaminase protein family, but is almost uniquely distributed in the prostate gland. Recent years have seen an expansion of interest in this enzyme, which is intriguingly expressed in prostate tissues and prostate cancer. In recent studies, the molecule has been found to have a diverse impact on prostate cancer cell growth, migration and invasiveness, and to be involved in the tumor--endothelial interaction and epithelial--mesenchymal transition, and has a wide interaction with other molecular complexes implicating it as a possible biomarker of aggressive versus nonaggressive cancer, as well as a therapeutic factor. This article reviews the recent progress and discusses the controversies and future directions in this exciting area of prostate cancer research.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Uncontrolled Keywords: cell invasion; epithelial--mesenchymal transition; melanoma differentiation associated gene-7/IL-24; prostate cancer; prostate transglutaminse; RON; TGM4; tumor--endothelial interactions
Publisher: Future Medicine
ISSN: 1752-0363
Last Modified: 04 Jun 2017 03:59

Citation Data

Cited 12 times in Google Scholar. View in Google Scholar

Cited 11 times in Scopus. View in Scopus. Powered By ScopusĀ® Data

Actions (repository staff only)

Edit Item Edit Item